News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
633,534 Results
Type
Article (14128)
Company Profile (362)
Press Release (619035)
Multimedia
Podcasts (48)
Webinars (2)
Section
Business (191993)
Career Advice (1379)
Deals (31321)
Drug Delivery (86)
Drug Development (64193)
Employer Resources (35)
FDA (14281)
Job Trends (13618)
News (282927)
Policy (24330)
Tag
2025 Best Places to Work (24)
2026 Best Places to Work (36)
2027 BioCapital Standard (3)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (1949)
Accelerated approval (52)
ADA (44)
Adcomms (17)
Allergies (214)
Alliances (40889)
ALS (255)
Alzheimer's disease (1732)
Antibody-drug conjugate (ADC) (671)
Approvals (15490)
Artificial intelligence (863)
ASCO (289)
Autoimmune disease (463)
Automation (75)
Bankruptcy (250)
Belgium (42)
Best Places to Work (11850)
BIO (70)
Biologics (114)
BIOSECURE Act (5)
Biosimilars (258)
BioSpace Insights (45)
Biotechnology (214)
Bispecific (55)
Bladder cancer (236)
Brain cancer (85)
Breast cancer (928)
Cancer (7273)
Cardiovascular disease (500)
Career advice (1141)
Career pathing (13)
CAR-T (389)
CDC (13)
CDMO (80)
Celiac Disease (6)
Cell therapy (1014)
Cervical cancer (67)
Clinical research (61266)
Collaboration (2669)
Commercialization (62)
Compensation (1915)
Complete response letters (62)
COVID-19 (1143)
CRISPR (135)
CRO (3)
C-suite (1613)
Cystic fibrosis (162)
Data (11136)
Decentralized trials (1)
Denatured (12)
Depression (168)
Dermatology (196)
Diabetes (719)
Diagnostics (7465)
Digital health (78)
Diversity (5)
Diversity, equity & inclusion (12)
Drug discovery (405)
Drug pricing (60)
Drug shortages (13)
Duchenne muscular dystrophy (281)
Earnings (76649)
Employer branding (5)
Employer resources (30)
ESMO (423)
Events (115644)
Executive appointments (1367)
Eye disease (21)
FDA (19400)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (25)
Frontotemporal dementia (39)
Funding (2093)
Gene editing (249)
Generative AI (53)
Gene therapy (676)
GLP-1 (812)
Government (2334)
Grass and pollen (6)
Guidances (443)
Healthcare (20099)
Hematology (222)
HIV (101)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (12)
IgA nephropathy (136)
Immunology and inflammation (159)
Immuno-oncology (124)
Indications (296)
Infectious disease (1483)
Inflammatory bowel disease (257)
Inflation Reduction Act (5)
Influenza (149)
Intellectual property (373)
Interviews (237)
IPO (16516)
IRA (12)
Job creations (2322)
Job search strategy (1014)
JPM (10)
Kidney cancer (26)
Kidney disease (164)
Labor market (9)
Layoffs (118)
Leadership (6)
Legal (5549)
Licensing (117)
Liver cancer (97)
Longevity (48)
Lung cancer (994)
Lung diease (21)
Lymphoma (536)
Machine learning (65)
Management (11)
Manufacturing (1257)
Marketing (39)
MASH (223)
Medical affairs (4)
Medical device (14826)
Medtech (15155)
Mergers & acquisitions (16533)
Metabolic disorders (1528)
mRNA (149)
Multiple sclerosis (238)
Multispecific (5)
NASH (20)
Netherlands (40)
Neurodegenerative disease (445)
Neuropsychiatric disorders (63)
Neuroscience (3534)
Neurotech (2)
NextGen: Class of 2026 (6728)
Non-profit (4732)
Now hiring (13)
Obesity (537)
Opinion (78)
Ovarian cancer (290)
Pain (319)
Pancreatic cancer (427)
Parkinson's disease (449)
Partnered (18)
Patents (737)
Patient advocacy (7)
Patient recruitment (978)
Patient selection (117)
Peanut (72)
People (52828)
Peptides (41)
Pharmaceutical (57)
Pharmacy benefit managers (19)
Phase 1 (19129)
Phase 2 (27162)
Phase 3 (19632)
Pipeline (14334)
Policy (48)
Postmarket research (1709)
Preclinical (7629)
Press Release (66)
Prostate cancer (391)
Psychedelics (29)
Radioligand (2)
Radiopharmaceuticals (391)
Rare diseases (1078)
Real estate (4622)
Recruiting (11)
Regenerative medicine (35)
Regulatory (22516)
Reports (45)
Research institute (1944)
Resumes & cover letters (214)
Rett syndrome (58)
RNA editing (21)
RSV (73)
Schizophrenia (183)
Series A (373)
Series B (259)
Service/supplier (13)
Sickle cell disease (122)
Spinal muscular atrophy (128)
Sponsored (10)
Startups (2671)
State (2)
Stem cells (6)
Stomach cancer (9)
Substance use disorders (19)
Supply chain (110)
Switzerland (23)
Tariffs (4)
The Weekly (35)
Vaccines (712)
Venture capital (25)
Weight loss (273)
Wet AMD (6)
Women's health (160)
Worklife (11)
Date
Today (168)
Last 7 days (856)
Last 30 days (3820)
Last 365 days (31124)
2026 (28231)
2025 (30026)
2024 (36085)
2023 (41671)
2022 (50543)
2021 (55008)
2020 (53919)
2019 (47475)
2018 (35082)
2017 (30206)
2016 (27641)
2015 (32694)
2014 (21604)
2013 (16105)
2012 (17584)
2011 (18759)
2010 (16726)
Location
Africa (549)
Alabama (114)
Alaska (7)
Arizona (383)
Arkansas (17)
Asia (35979)
Australia (5913)
California (17110)
Canada (4483)
China (1860)
Colorado (757)
Connecticut (765)
Delaware (532)
Europe (82495)
Florida (2613)
Georgia (561)
Hawaii (4)
Idaho (64)
Illinois (1369)
India (145)
Indiana (742)
Iowa (34)
Japan (767)
Kansas (147)
Kentucky (66)
Louisiana (68)
Maine (99)
Maryland (2010)
Massachusetts (12346)
Michigan (449)
Minnesota (935)
Mississippi (7)
Missouri (188)
Montana (38)
Nebraska (27)
Nevada (207)
New Hampshire (91)
New Jersey (4505)
New Mexico (37)
New York (4441)
North Carolina (2199)
North Dakota (14)
Northern California (8860)
Ohio (527)
Oklahoma (32)
Oregon (50)
Pennsylvania (3272)
Puerto Rico (26)
Rhode Island (62)
South America (900)
South Carolina (102)
South Dakota (2)
Southern California (6914)
Tennessee (284)
Texas (2833)
United States (60462)
Utah (520)
Vermont (2)
Virginia (423)
Washington D.C. (62)
Washington State (1361)
West Virginia (3)
Wisconsin (195)
Wyoming (4)
633,534 Results for "avidbio.com".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
City of Tustin Honors Avid Bioservices, the Reshoring Leader
October 30, 2026
·
2 min read
Press Releases
Avid Bioservices Appoints Maria Ebro Andreasen as Chief People Officer to Fuel Continued Growth and Talent Strategy
May 18, 2026
·
2 min read
Press Releases
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
February 10, 2025
·
2 min read
Business
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024
·
1 min read
Business
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
September 3, 2024
·
1 min read
Press Releases
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
July 1, 2024
·
1 min read
Press Releases
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
December 30, 2024
·
7 min read
Business
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO) today announced that it will report financial results for the second quarter of fiscal year 2024 on December 7, 2023, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
November 30, 2023
·
1 min read
Press Releases
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
January 9, 2025
·
9 min read
Biotech Beach
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023
Avid Bioservices, Inc. (NASDAQ:CDMO) today announced that it will report financial results for the first quarter of fiscal year 2024 on September 7, 2023, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
August 31, 2023
·
1 min read
1 of 63,354
Next